RAS inhibitors have opened a new chapter in the treatment of pancreatic cancer, but some tumours develop resistance to these drugs. Here, we explor...
The IDIBAPS Steering Committee approved in 2025 the creation of the new research group Translational oncology of upper gastrointestinal cancer. The...
Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre (4CB), is participating in the American Society of Clinica...
A team from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Centre, has participated in an international study th...
March 2026 marks five years since the creation of the Chair of Innovation in Precision Oncology (IOP), a strategic initiative of the University of...
An international team of experts has published the new 2026 International Consensus on cholangiocarcinoma in Nature Reviews Gastroenterology & Hepa...
February, particularly February 19, is dedicated to raising awareness about cholangiocarcinoma, a rare tumour in our setting where most patients ar...
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona, has announce...
